FDA Warns of Anaphylaxis Risk Linked to False Negatives from Certain Food Allergy Skin Tests
The FDA warns that some extracts used in allergy tests may result in false negative results, putting individuals at risk of serious anaphylaxis reactions.
Tag Archives: Anaphylaxis
-
-
NSAID Hypersensitivity Frequently Seen in Children, Study Warns
A new study finds a high rate of hypersensitivity in children to drugs like Motrin, Aleve and aspirin.
-
IV Iron Treatments Linked To Anaphylaxis Risk: Study
A new study finds some IV iron supplements may carry a higher than normal risk of anaphylaxis reactions.
-
Gadolinium-Based MRI Contrast Agents Linked To Hypersensitivity Reactions: Study
A new study links gadolinium-based contrast agents to hypersensitivity reactions which can sometimes be life-threatening.
-
Class Action Lawsuit Over EpiPen Pricing, Kickbacks Allowed to Proceed
Mylan must face a class action lawsuit over claims of price-fixing and bribery after a federal judge refused to dismiss their claims.
-
EpiPen Problems May Lead To Premature Device Activation, FDA Warns
Mylan and the FDA warn that EpiPens may go off prematurely if they experience sideways pressure, and in some cases may become stuck in their carriers.
-
New Flu And Migraine Drugs Approved By FDA On Scant Scientific Data, Raising Concerns: Report
New flu and migraine drugs may have unexpected side effects due to minimal clinical trial testing, according to a new report.
-
EpiPen Auto-Injectors May Get Stuck In Carrier Tube, FDA Warns
Mylan and the FDA warn that some EpiPen and EpiPen Jr. Auto-Injectors may jam due to problems with the label, preventing potentially life-saving epinephrine during a severe allergic reaction.
-
Infant Side Effects of Heartburn Drugs and Antibiotics May Increase Risk Of Allergies In Children: Study
A new study's findings indicate that giving infants heartburn drugs or antibiotics can increase their risk of developing all types of allergies later in childhood.
-
Deadline to File as Lead Plaintiff in Varubi Lawsuit Over Anaphylactic Shock is Today in Investor Class Action
Investors who wish to join the recently filed Varubi class action lawsuit have until today to file a motion to participate in the claim as a lead plaintiff.
